PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry

This whitepaper has been adapted from GlobalData’s “PharmaSphere: Early-Stage Technology Transfer Collaborations” report, completed by its Industry Dynamics Team in Boston, Massachusetts. The paper contains analysis on strategic deals involving pharmaceutical companies and academic and nonprofit research institutions, examining the terms, platform technologies and deal rationale. It also discusses macro-environment drivers, which are leading to an increase in research partnerships with academic institutions on behalf of pharmaceutical companies, the unsustainability of the current drug research model, and the industry’s attempts at moving toward an open R&D ecosystem.

PharmaLeaders: Generic Manufacturers Benchmark

Based on client feedback, GlobalData highlights 30 companies in the generic pharmaceuticals space, forming a basis for in-depth analysis of the current and future growth drivers of the generic pharmaceuticals market in certain markets. The report discusses the key factors shaping and driving the generic pharmaceutical industry, and provides insight on the competitive landscape and emerging strategies expected to significantly alter the market position of industry leaders.
Excerpt from PharmaLeaders: Generic Manufacturers Benchmark – Financial Benchmarking & Competitive Analysis of the Leading Generic Players

PharmaSphere: Global Generics Strategy

Using detailed company data, financial analysis, corporate strategy, and market trends analysis, GlobalData provides in-depth analysis of the current and future growth drivers of the generic pharmaceuticals industry. The whitepaper discusses the key factors shaping and driving the generic pharmaceutical industry, and provides insights on the competitive landscape and emerging strategies expected to significantly alter the market positions of industry leaders.
Excerpt from PharmaSphere: Global Generics Strategy – Key Drivers, Markets and Trends in 2013

Pre-IPO Valuation and Analysis of Quintiles Transnational

This special topic report is an essential source of information and analysis for the pre-IPO valuation of the Contract Research Organization (CRO) Quintiles Transnational. Using detailed company data, financial analysis, corporate strategy, and market trends analysis, GlobalData has created a discounted cash flow valuation of Quintiles, estimating what the value of the company will be at its IPO. The report discusses the key factors shaping and driving the company’s value, and provides insight on competitive comparables, and what the offering will mean for Quintiles and its current investors. Throughout the report, GlobalData’s analysts provide you with expert insight, expanding on each strategy and factor discussed, with the aim of providing you with the tools needed for understanding the IPO. This report is not an investment guide. GlobalData is not a registered financial institution and is not making investment recommendations in this report.

PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark (Report Extract)

In this whitepaper, GlobalData uses its proprietary ranking methodology to compare the competitive position of 15 innovative biotech companies by analyzing financial performance, cost-containment and firm utilization to illustrate the different strategies these companies are using to increase value for their shareholders. This whitepaper will help clients improve their strategic planning and tracking of competitor strategies, as well as enhance their understanding of critical pipeline advancements, significant M&A and licensing, agreements and revenue forecasts.

Assessing the impact of the UK’s domestic renewable heat incentive

The UK’s domestic renewable heat incentive (RHI), due to be introduced in 2013, is the least sexy of the government’s energy policy plans, but arguably the most important. Readers of this whitepaper will improve their understanding of the scheme in detail, be able to measure the impact on electricity and gas supply markets, and understand which technologies are most likely to be deployed under the scheme. The whitepaper also contains several recommendations for policy makers on how to target specific sectors in order to deliver the 12% target.

MediPoint: Bioabsorbable Stents - Analysis and Market Forecast to 2018

An in-depth look into the bioabsorbable stent market in the US and Europe, with evaluation of its future adoption, including whether the current unmet needs are being addressed and the potential of BAS to become a viable alternative to current treatments. Clients can use this whitepaper to better understand the scope of this technology and for strategic planning to explore opportunities in this growing market. Extract from our full report, MediPoint: Bioabsorbable Stents – Analysis and Market Forecast to 2018.

MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecasts

This whitepaper explores some of the key trends shaping and driving the high-potential global Transcatheter Aortic Valve Replacement (TAVR) market, providing insight into the competitive TAVR landscape, including new companies entering the market and pipeline products in development. It also examines the impact of this technology around the world, while investigating the highest growth sectors for TAVR, with a focus on countries leading the way.

Biotech Strategy 2012

This whitepaper, revealing the industry trends and deal-making strategies currently being used by successful companies to create and maintain market share in an increasingly demanding pharmaceuticals marketplace, will assist in strategic planning and tracking of competitor strategies.

Global Healthcare Policy Analysis 2012

An in-depth look at changes in healthcare policy and regulations in key countries and how they are affecting pharmaceutical companies, as well as analysis of how important events in 2012 will shape the global healthcare market in the future. Extract from our full report, Global Healthcare Policy Analysis 2012 – Regulatory, Pricing, and Reimbursement Assessment.

Pharmaceutical Leaders 2012

Analyze and emulate the strategies that successful companies are using to maintain their lead in the increasingly competitive global pharmaceutical market, while identifying the important disease areas, types of products and geographical areas successful companies are expanding into to ensure their future success. Extract from our full report, Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers.